Bio-Rad Laboratories (BIO) reported fourth quarter net income of $1.65 per share after the close Tuesday, down from $2.08 per share last year. The consensus estimate was for EPS of $1.34.
Shares of Bio-Rad Laboratories have been rising since the open Wednesday and are now up 5.11 at $122.41. The stock has been on an upward trend for the last 2 months and has set a new high for the year.
For comments and feedback: editorial@rttnews.com